newsfilter
← Latest News
GlobeNewswire·

Autolus Therapeutics Reports Second Quarter 2025 Financial Results and Business Updates

Company reports Q2 2025 AUCATZYL® net product revenue of $20.9 million and $29.9 for the first six months of 2025Company recently received conditional marketing authorization from U.K. Medicines and Healthcare